Sulzer AG ((CH:SUN)) has held its Q2 earnings call. Read on for the main highlights of the call.
Sulzer AG struck an unusually balanced tone in its latest earnings call, pairing robust margin expansion and operational progress with frank acknowledgment of order softness and cash‑flow strain. Management sounded confident about execution of its Sulzer Excellence program and the resilience of Flow and Services, yet cautioned that Chemtech, net working capital and geopolitical risks remain key swing factors for the rest of 2026.
Profitability Improvement
Sulzer delivered a clear profitability upgrade in the first half, even as top‑line dynamics stayed mixed. Group EBITDA margin rose to 15.5%, roughly 110 basis points higher than a year earlier, with absolute EBITDA and net income up in Swiss francs, helped by stronger gross margins and disciplined execution under the Sulzer Excellence efficiency program.
Flow Division Margin Momentum
The Flow division emerged as a margin standout, posting an EBITDA margin of 13.3%, up sharply from 8.7% in H1 2023. Order intake in Flow also regained momentum, swinging from a 3.8% decline in Q1 to 6.6% growth in Q2, signaling improving demand despite a volatile project environment.
Services Growth and Margin Expansion
Services continued to grow from an already elevated base, with H1 sales up 4.4% and a notable improvement in pricing quality. The order‑intake gross margin in Services increased by 140 basis points to 40.6%, lifting EBITDA margin by roughly 100 basis points even amid regional disruptions and delayed repair activity.
Book‑to‑Bill and Backlog Health
Despite softer headline orders, Sulzer reported book‑to‑bill ratios above 1.0 in most business units, supporting backlog visibility. Management highlighted a strengthening order pipeline and early signs that large projects are returning, though they expect these awards to be heavily back‑loaded into the second half and particularly the fourth quarter.
Sulzer Excellence Delivering Operational Gains
The Sulzer Excellence program featured prominently, credited with tangible operational gains across the group. Initiatives in on‑time and in‑spec delivery, more rigorous pricing, shorter order cycles and design‑to‑cost and supply‑chain actions were cited as major contributors to the margin uplift seen in H1.
Confirmed Full‑Year Guidance
Management reiterated its full‑year 2026 guidance, underscoring confidence in the underlying business despite near‑term noise. Sulzer continues to target order‑intake growth of 1% to 5%, sales growth of 2% to 5% and a full‑year EBITDA margin around 16.5%, implying further margin improvement from the already higher H1 level.
FX and Currency Management
Foreign‑exchange movements were a clear drag on reported numbers, cutting sales and orders by about CHF 100 million, or roughly 5%. Even so, Sulzer’s margin and profitability gains more than offset these currency headwinds in Swiss‑franc terms, helped by the operational savings embedded in Excellence measures.
Innovation and New Solutions
Beyond near‑term financials, Sulzer stressed progress in advanced technologies that could underpin long‑term growth. Examples include subsea CO2 reinjection pumps for Petrobras and Technip and trials of PEF polymers as potential PET replacements, signaling differentiation in decarbonization and sustainable materials.
Group Order Intake Decline
Headline order momentum was clearly weaker, with group order intake down 3.9% in the first half of 2026. Management framed the shortfall as relatively small in absolute terms, under CHF 80 million, but acknowledged that it reflected delayed and missed large project awards that weigh on visibility.
Chemtech Severe Headwinds
Chemtech remained the major problem area, reporting order intake down 22.7% and sales down 4.9% year on year. Large project delays and slower decisions in new technologies such as biopolymers, carbon capture and sustainable aviation fuels pushed Chemtech’s order‑intake gross margin down 3.6 percentage points to 32.3%.
MTCS and New Technologies Weakness
The MTCS and broader new‑technologies portfolio also suffered, with MTCS sales down around 18% in the period. While Chemtech’s order intake improved from a 27.7% drop in Q1 to a 16.1% decline in Q2, volumes and margins in these newer areas remain under significant pressure.
Higher Net Working Capital and Cash Impact
Cash generation was another weak spot as net working capital increased by roughly CHF 100–117 million year on year, pushing the NWC‑to‑sales ratio up to 26% from 22%. Fewer large down payments and the higher working‑capital needs reduced free cash flow, with management pointing to an approximate CHF 40 million cash impact.
Project Delays from Geopolitical Disruption
Geopolitics added another layer of uncertainty, with Middle East conflict and related supply‑chain issues, including disruptions around the Strait of Hormuz, slowing project execution. These delays have affected order intake and repair cycles, particularly in industry and fertilizer‑related business in the Flow and Services segments.
Restructuring and One‑offs in Chemtech
In response to the prolonged downturn in Chemtech, Sulzer has accelerated restructuring to resize the division. The company announced about a 10% reduction in Chemtech personnel over June–July and booked an impairment of around CHF 8 million for a Singapore R&D center, with further low single‑digit restructuring costs expected in the second half.
Order Intake Margin and Large Order Volatility
Group order‑intake margin slipped to 35.7%, down 60 basis points from the prior year, largely due to missing high‑margin PLA projects that boosted H1 2025. Management emphasized that volatility in securing large, specialized orders remains a feature of the business and can move margins materially from one period to the next.
Service Repair Delays
Even the resilient Services business is not immune to customer caution, particularly in repair work. The repair segment, roughly one‑fifth of Services, is seeing 20% to 30% of customers delay normal service cycles by weeks or months, as high fuel and pricing conditions push clients to extend maintenance intervals.
Forward‑Looking Guidance and Outlook
Looking ahead, Sulzer is banking on a catch‑up in orders and continued margin expansion to hit its full‑year targets. Management expects large orders to be back‑loaded into the second half, likely concentrated in the fourth quarter, while openly flagging a weak third quarter and the drag from higher working capital and Chemtech restructuring on cash and reported profit.
Sulzer’s earnings call painted a picture of a company sharpening its profitability and operational discipline while navigating a tougher order and cash environment. For investors, the key takeaway is that Flow and Services are offsetting Chemtech weakness, but the story now hinges on timing: if back‑loaded projects and restructuring deliver as planned, the margin‑driven thesis could remain intact despite near‑term volatility.